For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Changsha 410013

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Cardiovascular Diseases, Hepatocellular Carcinoma, Rheumatoid Arthritis

Studies at this site

• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed